Search for Clinical Trial Results
Myositis - 160 Studies Found
Status | Study |
Completed |
Study Name: Methimazole to Treat Polymyositis and Dermatomyositis Condition:
Date: 1999-11-03 Interventions: Drug: methimazole |
Completed |
Study Name: Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis Condition:
Date: 2013-03-13 Interventions: Drug: Immunosuppressive Agents Patients in the cohort received medical treatment according to standard c |
Completed |
Study Name: Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis Condition:
Date: 2002-04-11 Interventions: Drug: Infliximab |
Recruiting |
Study Name: Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study Condition: Dermatomyositis Date: 2014-10-15 Interventions: Drug: Immunoglobulin (Hizentra) Other Name: Immunoglobulin subcutaneous (human) 20% liquid, Hizentra |
Recruiting |
Study Name: Abatacept Treatment in Polymyositis and Dermatomyositis Condition:
Date: 2011-03-15 Interventions:
|
Completed |
Study Name: Arimoclomol in Sporadic Inclusion Body Myositis Condition: Inclusion Body Myositis Date: 2008-10-08 Interventions:
|
Completed |
Study Name: Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis Condition: Sporadic Inclusion Body Myositis Date: 2011-08-12 Interventions:
|
Completed |
Study Name: Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis Condition: Sporadic Inclusion Body Myositis (sIBM) Date: 2014-03-20 Interventions: Drug: BYM338 (Bimagrumab) |
Completed |
Study Name: Lithium in Inclusion Body Myositis (IBM) Condition: Inclusion Body Myositis Date: 2009-06-08 |
Not yet recruiting |
Study Name: Study of Arimoclomol in Inclusion Body Myositis (IBM) Condition: Inclusion Body Myositis Date: 2016-04-25 Interventions:
|